Xometry (NASDAQ:XMTR - Get Free Report) will likely be releasing its Q1 2026 results before the market opens on Thursday, May 7th. Analysts expect Xometry to post earnings of $0.11 per share and revenue of $188.4740 million for the quarter. Interested persons may visit the the company's upcoming Q1 2026 earning results page for the latest details on the call scheduled for Thursday, May 7, 2026 at 8:30 AM ET.
Xometry (NASDAQ:XMTR - Get Free Report) last posted its earnings results on Tuesday, February 24th. The company reported $0.16 EPS for the quarter, topping the consensus estimate of $0.12 by $0.04. The firm had revenue of $192.40 million during the quarter, compared to analysts' expectations of $183.37 million. Xometry had a negative net margin of 8.99% and a negative return on equity of 5.49%. The company's quarterly revenue was up 29.5% compared to the same quarter last year. During the same period last year, the company posted $0.06 EPS. On average, analysts expect Xometry to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.
Xometry Trading Down 2.5%
Shares of XMTR opened at $45.29 on Thursday. Xometry has a 1-year low of $24.65 and a 1-year high of $73.87. The company has a current ratio of 3.76, a quick ratio of 3.72 and a debt-to-equity ratio of 1.18. The firm's 50-day moving average price is $43.65 and its 200-day moving average price is $53.72. The firm has a market capitalization of $2.35 billion, a price-to-earnings ratio of -37.12 and a beta of 0.88.
Wall Street Analysts Forecast Growth
Several analysts have weighed in on XMTR shares. Wedbush cut their price objective on Xometry from $70.00 to $60.00 and set an "outperform" rating on the stock in a research report on Wednesday, February 25th. Royal Bank Of Canada decreased their target price on Xometry from $64.00 to $55.00 and set a "sector perform" rating for the company in a research report on Wednesday, February 25th. Citigroup lowered their target price on Xometry from $75.00 to $65.00 and set a "buy" rating for the company in a research note on Wednesday, February 25th. Weiss Ratings reaffirmed a "sell (e+)" rating on shares of Xometry in a research note on Wednesday, January 21st. Finally, Zacks Research upgraded Xometry from a "strong sell" rating to a "hold" rating in a report on Monday, March 2nd. Five analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company has a consensus rating of "Hold" and a consensus price target of $62.00.
View Our Latest Research Report on Xometry
Insiders Place Their Bets
In related news, Director Katharine Weymouth purchased 1,215 shares of the business's stock in a transaction that occurred on Friday, February 27th. The shares were bought at an average price of $41.15 per share, for a total transaction of $49,997.25. Following the purchase, the director directly owned 3,615 shares of the company's stock, valued at approximately $148,757.25. This represents a 50.63% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, President Sanjeev Singh Sahni sold 9,978 shares of the firm's stock in a transaction that occurred on Thursday, February 26th. The shares were sold at an average price of $43.45, for a total value of $433,544.10. Following the transaction, the president directly owned 113,022 shares of the company's stock, valued at approximately $4,910,805.90. This trade represents a 8.11% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders have sold 68,090 shares of company stock valued at $3,032,592. Insiders own 9.66% of the company's stock.
Institutional Investors Weigh In On Xometry
Institutional investors have recently modified their holdings of the stock. Royal Bank of Canada raised its position in shares of Xometry by 5.0% in the 1st quarter. Royal Bank of Canada now owns 60,669 shares of the company's stock worth $1,511,000 after purchasing an additional 2,899 shares during the last quarter. AQR Capital Management LLC purchased a new stake in Xometry during the 1st quarter valued at about $692,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in Xometry by 7.8% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 26,054 shares of the company's stock valued at $649,000 after purchasing an additional 1,877 shares during the last quarter. Goldman Sachs Group Inc. increased its stake in Xometry by 26.6% during the 1st quarter. Goldman Sachs Group Inc. now owns 452,682 shares of the company's stock valued at $11,281,000 after purchasing an additional 95,154 shares in the last quarter. Finally, Invesco Ltd. increased its stake in Xometry by 476.1% during the 2nd quarter. Invesco Ltd. now owns 238,390 shares of the company's stock valued at $8,055,000 after purchasing an additional 197,013 shares in the last quarter. 97.31% of the stock is owned by hedge funds and other institutional investors.
Xometry Company Profile
(
Get Free Report)
Xometry, Inc NASDAQ: XMTR operates a technology-driven marketplace that connects businesses with on-demand manufacturing capacity across a wide array of processes. Through its proprietary Instant Quoting Engine and Xometry Platform, the company streamlines sourcing for CNC machining, 3D printing, sheet metal fabrication, injection molding, urethane casting and other custom manufacturing services. By aggregating a network of thousands of vetted suppliers, Xometry offers rapid lead times, transparent pricing and real-time order tracking to customers in sectors ranging from automotive and aerospace to medical devices and industrial equipment.
Since its founding in 2013 and headquarters in Rockville, Maryland, Xometry has expanded its geographic reach to serve customers in North America, Europe and beyond.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Xometry, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xometry wasn't on the list.
While Xometry currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report